P3 Health Partners is 1.8x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | WGS | PIII |
|---|---|---|
| Market cap | $1.61 B | $2.96 B |
| US-listed rank | #2258 | #1816 |
| Revenue (latest FY) | $427.54M | $1.46B |
| Net income (latest FY) | -$21.00M | -$147.95M |
| Net margin | -4.9% | -10.1% |
| SEC filings | 748 | 387 |
P3 Health Partners is 1.8x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $1.61 B).
In their latest fiscal years, GeneDx Holdings Corp. reported $427.54M in revenue while P3 Health Partners reported $1.46B.
Full pages: GeneDx Holdings Corp. and P3 Health Partners, or browse the full rankings.